Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Alkermes plc. | Director | Ordinary Shares | 99.9K | $2.41M | $24.10 | Jun 29, 2024 | Direct |
Endo International plc | Director | Ordinary Shares | 100K | $626K | $6.26 | Jun 11, 2021 | Direct |
Alkermes plc. | Director | Non Qualified Stock Option (Right to Buy) | 17.5K | $537K | $30.72 | May 31, 2024 | Direct |
PROTHENA CORP PUBLIC LTD CO | Director | Stock Option (Right to Buy) | 15K | May 15, 2024 | Direct | ||
Alkermes plc. | Director | Restricted Stock Unit Award | 0 | Jun 29, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALKS | Alkermes plc. | Jun 29, 2024 | 3 | -$76.5K | 4 | Jul 1, 2024 | Director |
ALKS | Alkermes plc. | May 31, 2024 | 14 | $219K | 4 | Jun 4, 2024 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | May 15, 2024 | 1 | $0 | 4 | May 17, 2024 | Director |
ALKS | Alkermes plc. | Jul 7, 2023 | 3 | -$92.6K | 4 | Jul 10, 2023 | Director |
ALKS | Alkermes plc. | Jun 29, 2023 | 2 | $0 | 4 | Jun 30, 2023 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | May 17, 2023 | 1 | $0 | 4 | May 19, 2023 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | Jan 10, 2023 | 3 | -$233K | 4 | Jan 12, 2023 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | Dec 12, 2022 | 5 | -$273K | 4 | Dec 12, 2022 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | Nov 10, 2022 | 5 | -$249K | 4 | Nov 10, 2022 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | Oct 10, 2022 | 4 | -$248K | 4 | Oct 12, 2022 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | Sep 28, 2022 | 3 | -$417K | 4 | Sep 30, 2022 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | Jul 20, 2022 | 3 | -$397K | 4 | Jul 22, 2022 | Director |
ALKS | Alkermes plc. | Jul 7, 2022 | 2 | $0 | 4 | Jul 8, 2022 | Director |
ALKS | Alkermes plc. | Jun 14, 2022 | 3 | -$107K | 4 | Jun 16, 2022 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | May 18, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
ALKS | Alkermes plc. | May 2, 2022 | 3 | -$127K | 4 | May 3, 2022 | Director |
ALKS | Alkermes plc. | Apr 25, 2022 | 3 | -$113K | 4 | Apr 27, 2022 | Director |
ALKS | Alkermes plc. | Apr 18, 2022 | 3 | -$123K | 4 | Apr 19, 2022 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | Apr 11, 2022 | 5 | -$143K | 4 | Apr 13, 2022 | Director |
ALKS | Alkermes plc. | Apr 11, 2022 | 3 | -$127K | 4 | Apr 12, 2022 | Director |
ALKS | Alkermes plc. | Apr 4, 2022 | 3 | -$116K | 4 | Apr 5, 2022 | Director |
ALKS | Alkermes plc. | Dec 2, 2021 | 3 | -$64.1K | 4 | Dec 3, 2021 | Director |
ALKS | Alkermes plc. | Jun 14, 2021 | 2 | $0 | 4 | Jun 16, 2021 | Director |
ENDPQ | Endo International plc | Jun 11, 2021 | 2 | -$156K | 4 | Jun 15, 2021 | Director |
ALKS | Alkermes plc. | May 20, 2021 | 3 | -$69.6K | 4 | May 21, 2021 | Director |
PRTA | PROTHENA CORP PUBLIC LTD CO | May 19, 2021 | 1 | $0 | 4 | May 21, 2021 | Director |